11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples